Netilmicin in Gram-Negative Bacterial Infections

Netilmicin, a new semisynthetic aminoglycoside, was used in the treatment of 42 patients with serious gram-negative bacterial infections. Of the 40 evaluable patients, 24 (60%) were cured, and 8 (20%) had a favorable clinical response, for a total clinical response rate of 80%. Eight patients failed...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Snydman, David R., Tally, Francis P., Landesman, Sheldon H., Barza, Michael, Gorbach, Sherwood L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1979
Gaiak:
Pharmacology and Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC352599/
https://ncbi.nlm.nih.gov/pubmed/426506
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak